Alere BinaxNOW RSV
Device
Abbott Laboratories
Total Payments
$191,145
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $191,145 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $191,145 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| IMPRV RSV | Abbott Laboratories | $120,920 | 0 |
| IMRPV RSV | Abbott Laboratories | $70,225 | 0 |
Top Doctors Receiving Payments for Alere BinaxNOW RSV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $191,145 | 9 |
Ad
Manufacturing Companies
- Abbott Laboratories $191,145
Product Information
- Type Device
- Total Payments $191,145
- Total Doctors 0
- Transactions 9
About Alere BinaxNOW RSV
Alere BinaxNOW RSV is a device associated with $191,145 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $191,145 was paid across 9 transactions to 0 doctors.
The most common payment nature for Alere BinaxNOW RSV is "Unspecified" ($191,145, 100.0% of total).
Alere BinaxNOW RSV is associated with 2 research studies, including "IMPRV RSV" ($120,920).